secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001493152-25-022005
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions reports record Q1 revenue of $1.11M, up 28% YoY; gross margin expands to 46.6%
--------------------------------------------------------------------------------

- Revenue $1.11M (+28% YoY, +32% sequential); cartridge sales 57.6% of total revenue.
- Gross margin 46.6%, up 690 bps YoY, citing operational efficiency and product mix.
- Added 33 new customer accounts; total active accounts 492 across 24+ countries.
- Secured major contract with London public transport operator covering 14 sites and 4,400+ staff.
- Expanded portfolio with SmarTest® Patch and global distribution deal with SMARTOX®.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225022005/0001493152-25-022005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225022005/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-022005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer